" class="no-js "lang="en-US"> Pierre Vandepapelière - Medtech Alert
Saturday, September 13, 2025
Pierre Vandepapelière

Pierre Vandepapelière

About Pierre Vandepapelière

• Medical Doctor and PhD with over 20 years’ experience in pharmaceutical industry.

• Clinical development of complex programs from preclinical to phase 3 and registration.

• Expertise in infectious diseases, chronic inflammatory and auto immune diseases, vaccines, adjuvants and biological drugs.

• Leadership of multidisciplinary and multicultural teams in a large international pharmaceutical organization and hands on management of internal and external resources in a small Biotech company.

• Global experience in pharmaceutical development: clinical, regulatory affairs (Europe, North America, Asia), business development, marketing, safety, medical affairs, pre-clinical, interactions with non-governmental organizations,other pharmaceutical and biotech companies, investors, key opinion leaders, clinical investigators and contract research organizations.

Specialties: Prophylactic and therapeutic vaccines
Infectious diseases
Auto immune and inflammatory diseases
Clinical and global development

Related Story

Amyl Therapeutics Closes €18.3 million Series A Financing to Develop Novel Therapies for Amyloidosis

June 3 2021

Amyl Therapeutics (‘Amyl’), a preclinical stage biotechnology company developing its amyloid fibrils specific technology platform named […]